Pain Self-management Plus Nurse-led Support in Young Adults with Irritable Bowel Syndrome: Study Protocol for a Pilot Randomized Control Trial

Overview

Journal Res Nurs Health

Specialties Health Services
Nursing
Public Health

Date 2018 Feb 2

PMID 29388674

Citations 6

Authors

Xiaomei Cong

Divya Ramesh

Mallory Perry

Wanli Xu

Katherine M Bernier

Erin E Young

Stephen Walsh

Angela Starkweather

Affiliations

Soon will be listed here.

Abstract

Irritable bowel syndrome (IBS) is a functional gut disorder that typically manifests in early adult years. IBS patients report that pain is the most distressing symptom with the greatest impact on quality of life. Pain-sensitivity genes and the gut microbiome may influence severity of symptoms as well as response to self-management (SM) interventions. Based on current understanding of the science of SM, pain neurophysiology, and the gut-brain axis, our team developed a pain SM intervention to be added to evidence-based self-management instruction to increase the individual's SM knowledge and skills (self-efficacy, self-regulation, and goal-setting). The purpose of this randomized controlled longitudinal pilot study is to examine the feasibility, acceptability, and preliminary effectiveness of the IBS-pain SM intervention on IBS-pain SM behaviors and related health outcomes. A sample of 80 young adults (age 18-29 years old) will be recruited and randomly assigned to the experimental or control group. Both groups will receive 10 electronic video modules focused on IBS-pain SM knowledge and skills. The experimental group also will receive nurse-led one-on-one phone consultations to facilitate monitoring and problem-solving. All participants will be followed over 12 weeks. Primary outcomes will be measured at baseline, 6 weeks, and 12 weeks, including IBS-pain SM behaviors, quality of life, and well-being. The influence of pain-sensitivity genes and the gut microbiome on IBS-pain SM behaviors and health outcomes also will be assessed.

Citing Articles

Nurse-led self-management support to improve symptom management and self-reported outcomes in people with irritable bowel syndrome.

Barandouzi Z, Chen J, Henderson W, Starkweather A, Cong X Interdiscip Nurs Res. 2024; 3(3):163-168.

PMID: 39554222 PMC: 11567672. DOI: 10.1097/NR9.0000000000000069.

The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial.

Chen J, Zhang Y, Barandouzi Z, Lee J, Zhao T, Xu W Int J Nurs Stud. 2022; 132:104278.

PMID: 35640500 PMC: 10588769. DOI: 10.1016/j.ijnurstu.2022.104278.

The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome.

Zhao T, Zhang Y, Lee J, Starkweather A, Young E, Cong X J Pers Med. 2022; 12(2).

PMID: 35207633 PMC: 8878682. DOI: 10.3390/jpm12020142.

Design, methods, and baseline characteristics of the Brain Injury Education, Training, and Therapy to Enhance Recovery (BETTER) feasibility study: a transitional care intervention for younger adult patients with traumatic brain injury and caregivers.

Oyesanya T, Loflin C, You H, Kandel M, Johnson K, Strauman T Curr Med Res Opin. 2022; 38(5):697-710.

PMID: 35174756 PMC: 9131748. DOI: 10.1080/03007995.2022.2043657.

Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome.

Barandouzi Z, Lee J, Del Carmen Rosas M, Chen J, Henderson W, Starkweather A Sci Rep. 2022; 12(1):1648.

PMID: 35102266 PMC: 8803858. DOI: 10.1038/s41598-022-05756-0.

References

Whitehead W, Palsson O, Jones K . Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002; 122(4):1140-56. DOI: 10.1053/gast.2002.32392. View

Longstreth G, Wilson A, Knight K, Wong J, Chiou C, Barghout V . Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol. 2003; 98(3):600-7. DOI: 10.1111/j.1572-0241.2003.07296.x. View

Keller S, Bann C, Dodd S, Schein J, Mendoza T, Cleeland C . Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004; 20(5):309-18. DOI: 10.1097/00002508-200409000-00005. View

Frissora C, Koch K . Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep. 2005; 7(4):264-71. DOI: 10.1007/s11894-005-0018-9. View

Verdugo R, Ochoa J . Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels. Brain. 1992; 115 ( Pt 3):893-913. DOI: 10.1093/brain/115.3.893. View

Rolke R, Magerl W, Campbell K, Schalber C, Caspari S, Birklein F . Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2005; 10(1):77-88. DOI: 10.1016/j.ejpain.2005.02.003. View

Dishman R, Berthoud H, Booth F, Cotman C, Edgerton V, Fleshner M . Neurobiology of exercise. Obesity (Silver Spring). 2006; 14(3):345-56. DOI: 10.1038/oby.2006.46. View

Longstreth G, Grant Thompson W, Chey W, Houghton L, Mearin F, Spiller R . Functional bowel disorders. Gastroenterology. 2006; 130(5):1480-91. DOI: 10.1053/j.gastro.2005.11.061. View

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

10.

Kerckhoffs A, Samsom M, van der Rest M, de Vogel J, Knol J, Ben-Amor K . Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009; 15(23):2887-92. PMC: 2699007. DOI: 10.3748/wjg.15.2887. View

11.

Ryan P, Sawin K . The Individual and Family Self-Management Theory: background and perspectives on context, process, and outcomes. Nurs Outlook. 2009; 57(4):217-225.e6. PMC: 2908991. DOI: 10.1016/j.outlook.2008.10.004. View

12.

Jarrett M, Cain K, Burr R, Hertig V, Rosen S, Heitkemper M . Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions. Am J Gastroenterol. 2009; 104(12):3004-14. PMC: 2804069. DOI: 10.1038/ajg.2009.479. View

13.

Johannesson E, Simren M, Strid H, Bajor A, Sadik R . Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2011; 106(5):915-22. DOI: 10.1038/ajg.2010.480. View

14.

Karling P, Danielsson A, Wikgren M, Soderstrom I, Del-Favero J, Adolfsson R . The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One. 2011; 6(3):e18035. PMC: 3060919. DOI: 10.1371/journal.pone.0018035. View

15.

Kanazawa M, Hongo M, Fukudo S . Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2011; 26 Suppl 3:119-21. DOI: 10.1111/j.1440-1746.2011.06640.x. View

16.

Rajilic-Stojanovic M, Biagi E, Heilig H, Kajander K, Kekkonen R, Tims S . Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011; 141(5):1792-801. DOI: 10.1053/j.gastro.2011.07.043. View

17.

Ohman L, Stridsberg M, Isaksson S, Jerlstad P, Simren M . Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?. Am J Gastroenterol. 2012; 107(3):440-7. DOI: 10.1038/ajg.2011.458. View

18.

Tang Y, Yang W, Wang Y, Lin L . Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2012; 24(6):702-7. DOI: 10.1097/MEG.0b013e328351b2c2. View

19.

Dinan T, Cryan J . Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology. 2012; 37(9):1369-78. DOI: 10.1016/j.psyneuen.2012.03.007. View

20.

Simren M, Barbara G, Flint H, Spiegel B, Spiller R, Vanner S . Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2012; 62(1):159-76. PMC: 3551212. DOI: 10.1136/gutjnl-2012-302167. View